Newhouse H K, Wexler J P
Montefiore Medical Center, Albert Einstein College of Medicine, Department of Nuclear Medicine, Bronx, NY 10467, USA.
Semin Nucl Med. 1995 Jan;25(1):15-27. doi: 10.1016/s0001-2998(05)80003-0.
Myocardial perfusion imaging provides a means for evaluating the effects of interventional therapy in several groups of patients with coronary artery disease. In patients with unstable angina, imaging during or after chest pain can be used to identify areas of jeopardized myocardium and to predict the risk of subsequent cardiac events including myocardial infarction. In patients with acute myocardial infarction, the effect of thrombolytic therapy can be monitored, and in patients with chronic ischemia and left ventricular dysfunction, thallium imaging can be used to predict whether revascularization will improve myocardial function. In patients with stable coronary artery disease, perfusion imaging has been used to evaluate efficacy of anti-anginal medications. This article reviews the use of myocardial perfusion imaging in determining the need for, and success of, various medical and surgical therapeutic interventions in patients with ischemic heart disease.
心肌灌注成像为评估几组冠心病患者的介入治疗效果提供了一种手段。在不稳定型心绞痛患者中,胸痛发作期间或之后进行成像可用于识别心肌受威胁区域,并预测包括心肌梗死在内的后续心脏事件的风险。在急性心肌梗死患者中,可监测溶栓治疗的效果,而在慢性缺血和左心室功能障碍患者中,铊成像可用于预测血运重建是否会改善心肌功能。在稳定型冠心病患者中,灌注成像已用于评估抗心绞痛药物的疗效。本文综述了心肌灌注成像在确定缺血性心脏病患者各种药物和手术治疗干预的必要性及成功率方面的应用。